M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer

Overview of attention for article published in Frontiers in oncology, June 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 8,184 followers.

RT @FrontOncology: #ColorectalCancerAwarenessMonth Enhancing #Immunotherapy efficacy in #RectalCancer 👉 M6A “Writer” Gene METTL14: A Favo…

24 Mar 2022

Reply Repost Favourite

#ColorectalCancerAwarenessMonth Enhancing #Immunotherapy efficacy in #RectalCancer 👉 M6A “Writer” Gene METTL14: A Favorable Prognostic #Biomarker and Correlated With Immune Infiltrates in Rectal Cancer 👨‍⚕️👩‍⚕️: Cai C et al 👉 https://t.co/jdXaTtB2W5 @

24 Mar 2022

Reply Repost Favourite

New research: M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer: Rectal cancer (RC) is the leading cause of tumor-related death among both men and women. The efficacy of… https://t.co/Bhe4QP

17 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.